FY2025 EPS Estimate for Tango Therapeutics Lifted by Analyst
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Investment analysts at B. Riley boosted their FY2025 earnings estimates for Tango Therapeutics in a research note issued on Monday, June 9th. B. Riley analyst Y. Zhi now forecasts that the company will post earnings per share of ($1.37) for the year, up from their prior estimate […]
